معرفی
Yan Zhuang is an Assistant Professor in the Department of Pediatrics and Department of Cell and Biological Systems, focusing on pharmacology, oncology, and inflammation research. Their work primarily explores kinase inhibitors like Opaganib and ABC294640 for antitumor activity and anti-inflammatory applications.
Their recent publications highlight molecular mechanisms in cancer therapy, including vacuolar protein sorting and radiation toxicity protection, aligning with UN Sustainable Development Goals for health innovation. Key collaborations include Smith, C. D., Wang, H. G., and others.
- 2025: Targeting cancer cells via vacuolar protein sorting
- 2022: Opaganib's radiation protection
- 2018: Dual GSK3/CDK9 inhibition
- 2017: Sphingosine kinase-2 inhibitor trials
- 2011: Arthritis attenuation via kinase inhibition
With an h-index of 14 and over 1,899 citations, their research has been referenced in 2 patents and widely discussed in academic and media circles (e.g., 110 news outlets).
